circ_PTN contributes to -cisplatin resistance in glioblastoma via PI3K/AKT signaling through the miR-542-3p/PIK3R3 pathway

Glioblastoma has been identified as the most common and aggressive primary brain tumor in adults. Recently, it has been found that cisplatin (DDP) treatment is a common chemotherapeutic method for GBM patients. circ_PTN (ID number: hsa_circ_0003949) is a newly found circular (circRNA) which has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Hongcheng, Yi, Tingzhuang, Huang, Deyou, Chen, Xiaoping, Li, Xu, Wan, Qianquan, Huang, Haineng, Huang, Huadong, Wei, Hongyu, Song, Ye, Que, Tianshi, Hu, Rentong, Huang, Huatuo, Luo, Kunxiang, Li, Chuanyu, Qin, Chengjian, Zheng, Chuanhua, Lan, Chuanliu, Chen, Wencheng, Zhou, Dan, Luo, Qisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607136/
https://www.ncbi.nlm.nih.gov/pubmed/34853725
http://dx.doi.org/10.1016/j.omtn.2021.08.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607136/
https://www.ncbi.nlm.nih.gov/pubmed/34853725
http://dx.doi.org/10.1016/j.omtn.2021.08.034

Ejemplares similares